A 68-year-old female was diagnosed with RA 10 years earlier, and has been treated with etanercept (tumor necrosis factor alpha (TNF-α) inhibitor) for over 6 years, at 25 mg once every week. This evidence concerns the gene TNF and rheumatoid arthritis.